newsfilter
← Latest News
ACCESS Newswire·

ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies in Reproductive Medicine and Women's Health

Round led by Jeito Capital, co-led by AXA IM Alts and M Ventures, with strong syndicate support from Ysios Capital and ALSA Ventures LAUSANNE, SWITZERLAND AND COPENHAGEN, DENMARK / ACCESS Newswire / May 21, 2025 /